IM Cannabis (IMCC) Receivables (2019 - 2026)

IM Cannabis' Receivables history runs 8 years deep, the most recent figure standing at $5.2 million for Q1 2026.

• On a quarterly basis, Receivables fell 54.97% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 54.97% decrease from a year earlier, with the FY2025 full-year figure at $7.9 million, down 22.86% from the prior year.
• Receivables retreated to $5.2 million in Q1 2026 per IMCC's latest filing, from $7.9 million in the prior quarter.
• Across five years, Receivables topped out at $24.2 million in Q1 2022 and bottomed at $5.2 million in Q1 2026.
• The 5-year median for Receivables is $9.8 million (2023), against an average of $10.7 million.
• Across the five-year window, Receivables tumbled 69.8% in 2023 and jumped 59.69% in 2024, its largest moves.
• Year by year, Receivables stood at $6.5 million in 2022, then fell by 3.52% to $6.3 million in 2023, then soared by 59.69% to $10.1 million in 2024, then fell by 21.29% to $7.9 million in 2025, then slumped by 34.12% to $5.2 million in 2026.
• Per Business Quant, the three latest IMCC Receivables figures stand at $5.2 million (Q1 2026), $7.9 million (Q4 2025), and $8.2 million (Q3 2025).